Table 1 Dosimetry and dose constraints to critical normal structures

PTV1

Median 45.8 Gy (41.8–48.2Gy)

PTV2

Median 59.8 Gy (57.3–60.1Gy)

Mean Lung Dose

Median 10.3 Gy (6–15.3Gy)

Bilateral lung V20

Median 16.45% (7.6–33.1%)

Ipsilateral Lung V5

Median 62.45% (39.9–81.1%)

Ipsilateral Lung V20

Median 28% (17.9–42.5%)

Controlateral Lung V5

Median 45.75% (2.3–69.1%)

Controlateral lung V20

Median 16.35% (0.6–48%)

Heart V5

20.2% (7.1–66.1%)

Heart V30

2.75% (0–12.3%)

Esophagus V11.5

36% (21.1–68.5%)

Esophagus V18

45.15% (27.3–69.1%)

Esophagus V27

52.35% (26.9–69.8%)